Increased burden of cardiovascular disease in carriers of APOL1 genetic variants

Circulation Research

Volumn 114, Issue 5, 2014, Pages 845-850

  Ito, Kaoru ^a,b   Bick, Alexander G ^a,b   Flannick, Jason ^b,c   Friedman, David J ^a   Genovese, Giulio ^a,b   Parfenov, Michael G ^a   Depalma, Steven R ^a   Gupta, Namrata ^b   Gabriel, Stacey B ^b   Taylor, Herman A ^d,e,f   Fox, Ervin R ^d   Newton Cheh, Christopher ^b,c   Kathiresan, Sekar ^b,c   Hirschhorn, Joel N ^a,b,g   Altshuler, David M ^b,c   Pollak, Martin R ^a,b   Wilson, James G ^d   Seidman, J G ^a,b   Seidman, Christine ^a,b,h  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e JACKSON STATE UNIVERSITY   (United States)

^f TOUGALOO COLLEGE   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; chronic; continental population groups; epidemiology; genetics; renal insufficiency; risk factors

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; APOLIPOPROTEIN L1 GENE; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; FRAMESHIFT MUTATION; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONSENSE MUTATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; WOMEN'S HEALTH;

ATHEROSCLEROSIS; CONTINENTAL POPULATION GROUPS; EPIDEMIOLOGY; GENETICS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

ADULT; AFRICAN AMERICANS; AGED; APOLIPOPROTEINS; ATHEROSCLEROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INCIDENCE; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84895927552     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.302347     Document Type: Article

References (29)

1. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens. 2012;21:179-182.
2. Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, Safford MM, Cushman M, Glasser SP, Howard VJ. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173:46-51.
3. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G; REGARDS Investigators. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308:1768-1774.
4. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315.
5. Friedman DJ, Pollak MR. Genetics of kidney failure and the evolving story of APOL1. J Clin Invest. 2011;121:3367-3374.
6. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329:841-845.
7. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet. 2010;128:345-350.
8. Kopp JB, Nelson GW, Sampath K, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011;22:2129-2137.
9. Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: Relevance to antioxidative function. Arterioscler Thromb Vasc Biol. 2009;29:870-876.
10. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. Lancet. 2012;380:572-580.
11. Van Capelleveen JC, Bochem AE, Motazacker MM, Hovingh GK, Kastelein JJ. Genetics of HDL-C: A causal link to atherosclerosis Curr Atheroscler Rep. 2013;15:326.
12. Rye KA, Barter PJ. Cardioprotective functions of HDL. J Lipid Res. 2014;55:168-179.
13. Mineo C, Shaul PW. Novel biological functions of high-density lipoprotein cholesterol. Circ Res. 2012;111:1079-1090.
14. Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA Jr, Jaquish C. Study design for genetic analysis in the Jackson Heart Study. Ethn Dis. 2005;15:S6-30.
15. Design of the Womens Health Initiative clinical trial and observational study. The Womens Health Initiative Study Group. Control Clin Trials. 1998;19:61-109.
16. Bick AG, Flannick J, Ito K, et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet. 2012;91:513-519.
17. Tennessen JA, Bigham AW, OConnor TD, et al; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science. 2012;337:64-69.
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, De Bakker PI, Daly MJ, Sham PC. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
19. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909.
20. Tzur S, Rosset S, Skorecki K, Wasser WG. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Nephrol Dial Transplant. 2012;27:1498-1505.
21. Freedman BI, Langefeld CD, Turner J, Nez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012;82:805-811.
22. Van Der Bijl N, Joemai RM, Geleijns J, Bax JJ, Schuijf JD, De Roos A, Kroft LJ. Assessment of Agatston coronary artery calcium score using contrast-enhanced CT coronary angiography. AJR Am J Roentgenol. 2010;195:1299-1305.
23. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325.
24. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682-1687.
25. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772-1778.
26. Camici PG, Rimoldi OE, Gaemperli O, Libby P. Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. Eur Heart J. 2012;33:1309-1317.
27. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36-46.
28. Kahn MR, Robbins MJ, Kim MC, Fuster V. Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol. 2013;10:261-273.
29. Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, Carithers RL, Ragosta M, Bolton K, Auerbach AD, Eagle KA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease; American Heart Association; American College of Cardiology Foundation. Cardiac disease evaluation and management among kidney and liver transplantation candidates: A scientific statement from the American Heart Association and the American College of Cardiology Foundation: Endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation. 2012;126:617-663.